Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

J Vis Exp. 2023 Nov 17:(201). doi: 10.3791/65635.

Abstract

Acquiring fresh and well-characterized tumor tissue samples is critical for conducting high-quality "omics" studies. However, it can be particularly challenging in the context of prostate cancer (PC) due to the unique nature of this organ and the high heterogeneity associated with this tumor. On the other hand, histopathologically characterizing samples before their storage without causing significant tissue alterations is also an intriguing challenge. In this context, we present a new method for acquiring, mapping, characterizing, and micro-dissecting resected prostate tissue based on anatomopathological criteria. Unlike previously published protocols, this method reduces the time required for histopathological analysis of the prostate specimen without compromising its structure, which is crucial for assessing surgical margins. Furthermore, it enables the delineation and micro-macro dissection of fresh prostate tissue samples, with a focus on histological tumor areas defined by pathological criteria such as Gleason score, precursor lesions (high-grade prostatic intraepithelial neoplasia - PIN), and inflammatory lesions (prostatitis). These samples are then stored in a Biobank for subsequent research analyses.

Publication types

  • Video-Audio Media

MeSH terms

  • Biological Specimen Banks
  • Humans
  • Male
  • Prostate / pathology
  • Prostate / surgery
  • Prostatic Intraepithelial Neoplasia* / pathology
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / surgery
  • Reproducibility of Results